Medical cannabis as an alternative therapeutics for Parkinsons' disease: Systematic review.

@article{Bougea2020MedicalCA,
  title={Medical cannabis as an alternative therapeutics for Parkinsons' disease: Systematic review.},
  author={Anastasia Bougea and Christos Koros and Athina-Maria Simitsi and Chrysa Chrysovitsanou and Athanasios Leonardos and Leonidas Stefanis},
  journal={Complementary therapies in clinical practice},
  year={2020},
  volume={39},
  pages={
          101154
        }
}
Randomized controlled trials on the use of cannabis-based medicines in movement disorders: a systematic review
TLDR
A systematic review of randomized controlled trials on the use of cannabinoids in MD found no improvement of motor symptoms was shown in any of the two RCTs with this as primary outcome (PO), but in the nabilone group, an improvement in quality of life was documented.
Cannabis and its derivatives for the use of motor symptoms in Parkinson’s disease: a systematic review and meta-analysis
TLDR
Although observational studies establish subjective symptom alleviation and interest in MC among PD patients, there is insufficient evidence to support its integration into clinical practice for motor symptom treatment.
Effects of Cannabidiol on Parkinson's Disease in a Transgenic Mouse Model by Gut-Brain Metabolic Analysis
TLDR
CBD could attenuate PD via the neuroprotective effect on the midbrain and improve motor performance of PD, which might be partially induced by the metabolic interaction between the gut-brain.
Recent developments in geriatric psychopharmacology
TLDR
This is a non-systematic, narrative review of developments in disease-modifying therapies forAD, diagnostic radiotracers for AD, medications for neuropsychiatric symptoms of dementia, ketamine/esketamine, psychedelics, and cannabinoids that covers developments in the last 6 years.
Weeding through the haze: a survey on cannabis use among people living with Parkinson’s disease in the US
TLDR
The results suggest that the lack of formal guidance or research evidence about cannabis for PD may in part underlie inconsistencies in both use and reported effectiveness.
A Systematic Review of Trends in US Attitudes toward Cannabis Legalization
Abstract Introductions: In the United States (US), support for cannabis legalization has increased over time. This study examines historical changes in legalization attitudes and the period-specific
Cannabinoids as Key Regulators of Inflammasome Signaling: A Current Perspective
TLDR
In the milieu of coronavirus disease-2019 (COVID-19) pandemic, available evidence linking inflammasome activation to the pathophysiology of CO VID-19 is conferred suggesting overall, the importance of cannabinoids as possible drugs to target inflammaome activation in or to support the treatment of a variety of human disorders including COVID- 19.
Case Report: Secondary bilateral parkinsonism and dystonia treated with dronabinol
TLDR
Dronabinol resulted in improvement of pain and gait disturbance, suggesting a novel therapeutic strategy in these challenging patients with bilateral painful dystonia and parkinsonism caused by polyintoxication.
Case Report: Secondary bilateral parkinsonism and dystonia treated with dronabinol.
TLDR
Dronabinol resulted in improvement of pain and gait disturbance in patients with bilateral painful dystonia and parkinsonism caused by polyintoxication, suggesting a novel therapeutic strategy in these challenging patients.
...
...

References

SHOWING 1-10 OF 41 REFERENCES
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.
TLDR
There was moderate- quality evidence to support the use of cannabinoids for the treatment of chronic pain and spasticity and low-quality evidence suggesting that cannabinoids were associated with improvements in nausea and vomiting due to chemotherapy, weight gain in HIV infection, sleep disorders, and Tourette syndrome.
Cannabis (Medical Marijuana) Treatment for Motor and Non–Motor Symptoms of Parkinson Disease: An Open-Label Observational Study
TLDR
The study suggests that cannabis might have a place in the therapeutic armamentarium of PD, with significant improvement of sleep and pain scores and no significant adverse effects of the drug were observed.
Cannabis for dyskinesia in Parkinson disease
TLDR
Orally administered cannabis extract resulted in no objective or subjective improvement in dyskinesias or parkinsonism in Parkinson disease patients.
Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial
TLDR
The findings point to a possible effect of CBD in improving quality of life measures in PD patients with no psychiatric comorbidities; however, studies with larger samples and specific objectives are required before definitive conclusions can be drawn.
Medical Cannabis in Parkinson Disease: Real-Life Patients' Experience
TLDR
Medical cannabis was found to improve symptoms of PD in the initial stages of treatment and did not cause major adverse effects in this pilot, 2-center, retrospective survey.
[Cannabis in Parkinson's Disease: Hype or help?]
TLDR
An overview of the various cannabis products that can be prescribed, the different modes of administration and the available literature regarding motor- and non-motor symptoms in Parkinson's disease is provided.
The therapeutic potential of cannabinoids for movement disorders
TLDR
Clinical observations and clinical trials of cannabinoid‐based therapies suggests a possible benefit of cannabinoids for tics and probably no benefit for tremor in multiple sclerosis or dyskinesias or motor symptoms in PD.
Marijuana for Parkinson's Disease?
TLDR
Until studies clarify the safety and efficacy of pharmacotherapy with cannabis products, medical marijuana remains largely without scientific endorsement.
Effects of acute cannabidiol administration on anxiety and tremors induced by a Simulated Public Speaking Test in patients with Parkinson’s disease
TLDR
Acute CBD administration at a dose of 300 mg decreased anxiety in patients with PD, and there was also decreased tremor amplitude in an anxiogenic situation.
...
...